M Faraci
Overview
Explore the profile of M Faraci including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
48
Citations
367
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Faraci M, Bonaretti C, DellOrso G, Pierri F, Giardino S, Angiero F, et al.
Sci Rep
. 2024 Mar;
14(1):6708.
PMID: 38509104
The oral and gastrointestinal mucosae represent the main targets of the toxic effect of chemo and/or radiotherapy administered during the conditioning regimen before hematopoietic stem cell transplant (HSCT). These harmful...
2.
Diesch-Furlanetto T, Rovo A, Galimard J, Szinnai G, Dalissier A, Sedlacek P, et al.
Hum Reprod
. 2021 Sep;
36(11):2871-2882.
PMID: 34529796
Study Question: What are the characteristics of patients with conceptions transplanted in childhood and adolescence? Summary Answer: Insemination and conception after hematopoietic stem cell transplantation (HCT) in childhood or adolescence...
3.
Giaccone L, Mancini G, Mordini N, Gargiulo G, De Cecco V, Angelini S, et al.
Bone Marrow Transplant
. 2017 Oct;
53(1):58-63.
PMID: 29084200
Several guidelines have been published about management of chronic GvHD (cGvHD), but the clinical practice still remains demanding. The Gruppo Italiano Trapianto di Midollo Osseo (GITMO) has planned a prospective...
4.
Diesch T, Rovo A, von der Weid N, Faraci M, Pillon M, Dalissier A, et al.
Bone Marrow Transplant
. 2017 Jan;
52(7):1022-1028.
PMID: 28112743
Chemotherapy and irradiation can affect the gonads, leading to impairment of pubertal development and/or infertility. Fertility preservation (FP) is therefore a crucial endeavor in hematopoietic stem cell transplantation (HSCT) because...
5.
Bresters D, Lawitschka A, Cugno C, Potschger U, Dalissier A, Michel G, et al.
Bone Marrow Transplant
. 2016 Jun;
51(11):1482-1489.
PMID: 27348540
Younger children are considered to be more vulnerable to late effects (LE), which prompted us to study LE in patients after haematopoietic stem cell transplantation (HSCT) for a haematological malignancy...
6.
Lawitschka A, Faraci M, Yaniv I, Veys P, Bader P, Wachowiak J, et al.
Bone Marrow Transplant
. 2015 Jan;
50(4):592-7.
PMID: 25621804
The aim of this analysis was to explore the diversity of reduced intensity conditioning (RIC) in paediatric allo-SCT in daily practice across Europe. Data from the European Group for Blood...
7.
Naselli A, Faraci M, Lanino E, Morreale G, Cangemi G, Bandettini R, et al.
Bone Marrow Transplant
. 2014 Sep;
50(1):137-8.
PMID: 25243625
No abstract available.
8.
Thiel U, Koscielniak E, Blaeschke F, Grunewald T, Badoglio M, Diaz M, et al.
Br J Cancer
. 2013 Oct;
109(10):2523-32.
PMID: 24149176
Background: Allogeneic haematopoietic stem cell transplantation (allo-SCT) may provide donor cytotoxic T cell-/NK cell-mediated disease control in patients with rhabdomyosarcoma (RMS). However, little is known about the prevalence of graft-vs-RMS...
9.
Cesaro S, Pillon M, Tridello G, Aljurf M, Martino R, Schroyens W, et al.
Bone Marrow Transplant
. 2012 Dec;
48(6):809-13.
PMID: 23222380
To investigate the relationship between clinical response and modification of BK viremia, we assessed retrospectively 32 cases of hemorrhagic cystitis (HC) after allogeneic hematopoietic SCT that were treated with i.v....
10.
Faraci M, Lanino E, Morreale G, Giardino S, Fossati M, Moroni C, et al.
Bone Marrow Transplant
. 2010 Apr;
46(1):159-60.
PMID: 20383214
No abstract available.